MedTrace Logo

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

NCT00885300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2009-04-21

No results posted yet for this study

Summary

The purpose of this study is to investigate whether cloxacillin lock is effective in prevention of double lumen infection.

Conditions

  • Double Lumen Infection
  • Hemodialysis

Interventions

DRUG

cloxacillin

cloxacillin 100mg/ml as catheter lock at the end of hemodialysis

DRUG

heparin

heparin 1000iu/ml as catheter lock at the end of hemodialysis

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    lead OTHER

Principal Investigators

  • maryam pakfetart, assistant professor · Shiraz nephro-urology research center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-07-31
Completion
2008-09-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00885300 on ClinicalTrials.gov